Sepsis is characterized by the host’s dysregulated immune response to an infection followed by a potentially fatal organ dysfunction. Although there have been some advances in the treatment of sepsis, mainly focused on broad-spectrum antibiotics, mortality rates remain high, urging for the search of new therapies. Oxidative stress is one of the main features of septic patients, so antioxidants can be a good alternative treatment. Agaricus brasiliensis is a nutraceutical rich in bioactive compounds such as polyphenols and polysaccharides, exhibiting antioxidant, antitumor, and immunomodulatory activities. Here, we investigated the immunomodulatory and antioxidant effects of A. brasilensis aqueous extract in the cecal ligation and puncture (CLP) sepsis model. Our data showed that aqueous extract of A. brasiliensis reduced systemic inflammatory response and improved bacteria clearance and mice survival. In addition, A brasiliensis decreased the oxidative stress markers in serum, peritoneal cavity, heart and liver of septic animals, as well as ROS production (in vitro and in vivo) and tert-Butyl hydroperoxide-induced DNA damage in peripheral blood mononuclear cells from healthy donors in vitro. In conclusion, the aqueous extract of A. brasiliensis was able to increase the survival of septic animals by a mechanism involving immunomodulatory and antioxidant protective effects.
According to the World Health Organization (WHO), sepsis leads to about 6 million deaths per year worldwide (1) and is considered the main cause of death in intensive care units, especially in patients with comorbidities (2, 3). Sepsis is currently defined as a syndrome caused by a dysregulated immune response to infection (4) accompanied by an imbalance between pro-oxidant and antioxidant defenses in response to pro-inflammatory cytokines, nitric oxide (NO) and reactive oxygen species (ROS), which can cause lipid peroxidation, DNA damage, mitochondrial dysfunction, and multiple organ failure (5–7). Thus, new therapies based on compounds with antioxidant and/or immunomodulatory action may be effective as alternative therapy.
To study the pathogenesis and therapeutic targets in sepsis, several animal models have been widely used, but cecal ligation puncture (CLP) procedure is considered one that most closely resembles human sepsis (8). Recently, our group showed that in a murine model of moderate CLP-induced sepsis, animal mortality (up to six days after sepsis) was correlated with increased leukocyte migration to the peritoneal cavity and oxidative stress in several organs (spleen, heart, liver and lung) within 24 h of infection (9) and that the pretreatment of animals with salivary gland extract from Aedes aegypti improved mice survival through immunomodulatory and antimicrobial effects associated with lower oxidative status (decreased lipid peroxidation and increased antioxidant defense) (9). In this regard, it is of great interest to research new therapies with antioxidant and immunomodulatory properties through nutraceuticals such as Agaricus brasiliensis (Ab) (10).
Ab is a mushroom rich in bioactive compounds such as organic acids, amino acids, phenolic compounds and polysaccharides such as β-glucans (11, 12). The β-glucans found in mushrooms like Ab have a β-(1–3) structure associated with β-(16), which is able to stimulate cellular and humoral immune response, increase NO production, phagocytosis and lymphocyte proliferation (13–15). According to Carvajal et al., Ab present compounds such as lactic and fumaric acid, as well as secondary metabolites such as sesquiterpenes, steroids, anthraquinones, quinolines and derivatives of benzoic acid, inhibitors of bacterial growth (10). In addition, Ab has a high antioxidant potential mainly due to the presence of phenolic compounds such as gallic acid, serum acid and pyrogallol, karmic acid and other compounds such as ascorbic acid and α-tocopherol (11, 12, 16).
Therefore, considering sepsis as one of the major global public health challenges, the urgency for new therapeutic alternatives and the immunomodulatory properties of Ab, the aim of this study was to evaluate for the first time the effects of prophylactic administration of aqueous extract of Ab on survival, immunological and oxidative parameters in a murine sepsis model.
Materials and Methods
This study was carried out in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals of the Brazilian National Council of Animal Experimentation (http://www.sbcal.org.br/) and the NIH Guidelines for the Care and Use of Laboratory Animals. The institutional Committee for Animal Ethics of Federal University of Pará/UFPA (CEUA, Protocol: 02/15) approved all the procedures used in this study.
To in vitro tests, human venous blood was collected from healthy volunteers that signed the Informed Consent Form (ICF). This study was approved by the Institutional Committee of Ethics in Research involving human beings from the health sciences sector of UFPA (CEP-ICS/UFPA), under n° 3544380 and CAAE 12776619.0.0000.0018.
Male Swiss mice (7–8 weeks old) were used in this study and were obtained from the Animal Facility of the Federal University of Pará. Mice were kept in cages under controlled conditions of temperature (22 ± 3°C), light (12 h light/dark cycle) with food and water ad libitum, and acclimatized conditions for 3 days before use.
Preparation of Agaricus brasiliensis (Ab) Aqueous Extract
Ab was kindly donated by Dr. Herta Stutz Dalla Santa from the fungi collection of bioprocesses of the Bioprocesses Laboratory, Food Engineering Department, Universidade Estadual do Centro Oeste (UNICENTRO), Paraná, Brazil. To obtain an Ab aqueous extract rich in bioactive substances such as carbohydrates, in special β-glucans, proteins and phenolic compounds (17–19), we used a methodology described before (20), where 20 g of dried and pulverized mycelium of Ab were boiled in 20 mL of distilled water for 10 min and then the solution was filtered and lyophilized. A stock solution at 100 mg/mL was prepared in sterile distilled water and used for in vivo (135 mg/Kg) and in vitro experiments (2.81 and 22.5 mg/mL). These doses were chosen based on in vitro tests of cytotoxicity using macrophages and peripheral blood mononuclear cells. Before initiate the experimental sets, the antioxidant activity of Ab aqueous extract was confirmed by the in vitro assay for total antioxidant activity (TAC) (data not shown).
Design of in vivo Experiments
The animals were separated into 4 groups according to the treatment schedule, as follows: saline (saline 0.9% + cecal ligation and puncture –CLP/ n = 18 animals), Ceftriaxone (Cef −20 mg/kg + CLP/ n = 6 animals), aqueous extract of Ab (Ab −135 mg/kg + CLP, n = 18 animals) and sham (surgery control, n = 18 animals). All treatments were administered in a volume of 100 μL orally by gavage, 24 h before and immediately before CLP induction (time 0). In the first set of experiments, 24 animals were used to monitor the survival rate during 12 days. In the next set of experiments 36 animals were used, septic mice were euthanized at specific time points to evaluate the therapeutic potential and immunomodulatory/antioxidant activities of Ab. In this study, 18 mice (6/group) were euthanized 12 h after CLP to analyze oxidative stress parameters and 18 mice (6/group) were euthanized 24 h after CLP to analyze pro-inflammatory cytokines based on previous studies
The polymicrobial sepsis was induced using the cecal ligation and puncture (CLP) model according to D’Acampora and Locks, with some adaptations (9, 22). To summarize, animals were anesthetized with intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg), a small one-centimeter laparotomy performed, and the cecum exposed and then ligated using a 3–0 silk suture. Then, the cecum was punctured one single time with 22G needle to induce a moderate severity CLP. The cecum was gently squeezed to extrude a small amount of fecal content and was left to its original position in the abdominal cavity. Sham-operated mice underwent the same procedure, except for ligation and perforation of the cecum. The abdominal wall was closed, and fluid resuscitation was conducted with subcutaneous injection of 1 mL of saline 0.9%.
Survival and Weight Analysis of Septic Mice
After induction of sepsis, mice of each group (n = 6) were weighted twice a day for twelve consecutive days. To reduce suffering, mice presenting signs of imminent death (i.e., ataxia, inability to maintain upright position, tremor, and/or agonal breathing) were euthanized by ketamine/xylazine (>100/10 mg/kg, sc) overdose. The animals that survived for longer than 12 days were euthanized. The survival rate and weight were calculated followed by delineation of survival and weight curve.
Blood Samples and Leukocyte Counts
Peripheral blood was obtained by cardiac puncture of mice anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/Kg) at 12 and 24 h after CLP induction. Aliquots (500 μL) of blood collected with ethylenediamine tetraacetic acid (EDTA) 5% were analyzed using an automatic hematologic analyzer (Hematoclin 2.8 VET, Starlab, Salvador, BA, BRA) and blood samples (1000 μL) collected without anticoagulant were used to obtain serum for analyses of oxidative stress (12 and 24 h post CLP) and cytokines (24 h post CLP).
The levels of TNF-α and IL-1β in serum and peritoneal lavage fluid collected at 24 h post CLP induction were quantified by Enzime-Linked Immunosorbent Assay (ELISA) using an appropriate commercial kit (R&D Systems, Minneapolis, Canada) according to the manufacturer’s instructions. The detection limits of each cytokine were IL-1β, 12.5–800 pg/mL with sensitivity of 4.8 pg/mL; TNF-α, 10.9–700 pg/mL with sensitivity of 7.21 pg/mL.
Determination of Nitric Oxide (NO) Production
The nitrite (NO2) was estimated colorimetrically at 12 and 24 h post CLP on the basis of reduction of nitrate to nitrite using Griess method (23). Nitrite level was determined in 100 μL of samples (serum and lavage peritoneal) incubated with an equal volume of Griess reagent for 10 min at room temperature. The absorbance was measured at 550 nm and calculated from a standard curve with sodium nitrite expressed per μMol/mL (24).
Bacterial Load Determination
For determination of colony-forming units (CFU) in blood and peritoneal fluid of mice (n = 6 per/group), 10 μL of samples were diluted with sterile Phosphate-Buffered Saline (PBS) 1:10, and then 10 μL of each dilution was cultured in Müller Hinton Agar and incubated at 37 °C for 24 h. The colonies were counted and expressed in CFU/mL.
Peritoneal Leukocyte Counts
Twenty-four h after sepsis induction, peritoneal cells of animals were harvested with 3 mL of PBS containing 1 mM EDTA and the number of total leukocytes was determined using a hemocytometer. The number of differential cell counts was carried out counting a total of 200 cells on cytocentrifuge slides stained with panoptic dye. The results are presented as the number of neutrophils and mononuclear cells per cavity.
Phagocytic Capacity of Peritoneal Macrophages
The phagocytic capacity of peritoneal macrophages of septic and sham mice was evaluated as previously described (25). Peritoneal macrophages from sham, CLP-saline and CLP-Ab groups were collected 24 h post sepsis induction and incubated in 96-well microplates (2 x 105 cells/well) for 40 min at 37°C and 5% CO2. Then, 10 μL of neutral-red stained zymosan (1 × 108 particles/mL) were added to each well and after 30 min the supernatants were removed and cells fixed with Baker’s formol-calcium (4% formaldehyde, 2% sodium chloride, 1% calcium acetate) for 30 min. Following, the cells were washed two times by centrifugation in PBS (450g for 5 min). After solubilization of neutral-red stain with 0.1 mL of acidified alcohol (10% acetic acid, 40% ethanol in distilled water) the absorbance was measured in a microplate reader at 550 nm.
Measurement of Reactive Oxygen Species (ROS) Production
Reactive oxygen species (ROS) production in peritoneal macrophages of septic animals was quantified using 2′,7′-Dichlorodihydrofluorescein diacetate (H2DCF-DA) (26). Briefly, peritoneal cells obtained 24 h post CLP induction were incubated at 37° C during 15 min with 30 mM N-(2-Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) (HEPES) (pH 7.2), 200 mM KCl, 1 mM MgCl2, and 16 μM of H2DCF-DA. The conversion of DCFH-DA to the fluorescent product DCF was measured using a fluorescence microplate reader (Victor 2, Perkin Elmer) every 5 min during 30 min with excitation/emission at 488/530 nm. Background fluorescence was determined before the addition of H2DCF-DA and data were expressed as fluorescence intensity.
Determination of Lipid Peroxidation
Lipid peroxidation was measured in serum, peritoneal cavity, heart and liver samples collected from septic animals at 12 and 24 h post CLP induction as an indicator of oxidative stress, using the thiobarbituric acid-reactive substances (TBARS) assay (27, 28). Briefly, samples were mixed with 0.05 M trichloroacetic acid (TCA) and 0.67% thiobarbituric acid (TBA; Sigma-Aldrich, St. Louis, MO) in 2 M sodium sulfate, and heated in a water bath at 94°C for 90 min. The chromogen formed was extracted in n-butanol and measured at 535 nm. An MDA standard solution was used to construct a standard curve against which unknown samples were plotted. Results are expressed as malondialdehyde equivalents in nmol/L.
Total Evaluation of Trolox Equivalent Antioxidant Capacity (TEAC)
The total antioxidant capacity (TAC) of serum, peritoneal fluid, heart and liver samples of septic mice (collected 24 h post CLP induction) was evaluated by Trolox ((±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid; Sigma-Aldrich) equivalent antioxidant capacity assay (TEAC), which provides relevant information that may effectively describe the dynamic equilibrium between pro-oxidant and antioxidant compounds. In this assay, 2,2′-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) (Sigma Aldrich) was incubated with potassium persulphate (Sigma Aldrich) to produces ABTS∙+, a green/blue chromophore. The inhibition of ABTS∙+ formation by antioxidants in the samples were expressed as Trolox equivalents, determined at 740 mm using a calibration curve plotted with different amounts of Trolox (Sigma Aldrich) (29, 30).
Glutathione (GSH) Levels
The level of GSH was determined in samples of serum and peritoneal lavage fluid of septic mice at 12 and 24 h post CLP induction using Ellman’s reagent (31). This assay was based on the production of yellow color when 5,5′-Dithiobis(2-nitrobenzoic acid) (DTNB) is added to compounds containing sulfhydryl groups. The GSH concentration was determined using a standard curve constructed with different concentrations of GSH in the reduced form. The absorbance was recorded at 412 nm in a microplate reader (SpectraMax 250, Molecular Devices, Union City, CA, USA) and results were expressed in μmol/mL.
In vitro Studies
Peripheral Blood Mononuclear Cells (PBMC) Isolation and in vitro Stimulation
PBMC of healthy volunteers who were abstainers of alcohol and tobacco (both sexes, ages 20 to 45 years) were isolated from blood using Ficoll (Sigma-Aldrich). PBMC viability was determined by trypan blue exclusion and the viability was always >95%. Then, the cells were washed and suspended in Roswell Park Memorial Institute-1640 medium (RPMI-1640, Sigma-Aldrich) supplemented with 2 g/L sodium bicarbonate, 10% fetal bovine serum (FBS, Sigma-Aldrich), 2% glutamine, and 100 U/mL penicillin-0.1 mg/mL streptomycin (Sigma-Aldrich) and incubated in vitro with RPMI medium (control), tert-Butyl hydroperoxide (tBHP: 200 μM) or tBHP plus Ab (22.5 mg/mL) for 30 min at 37°C.
Measurement of Reactive Oxygen Species (ROS) Production
In this assay, mice were injected intraperitoneally with 2.5 mL of 3% thioglycollate (Sigma-Aldrich) and 48 h latter, peritoneal macrophages were harvested as previously described in 2.10. Macrophages (2 × 105) were incubated in vitro with tBHP (40 μM) or tBHP plus A. brasilienses (22.5 mg/mL) for 30 min at 37°C. ROS production was detected as described in item 2.11 (32).
DNA Damage Using Comet Assay
PBMC were treated in vitro with tBHP (200 μM) or tBHP plus A. brasilienses (2.81 or 22.50 mg/mL) for 3 h. To perform the Comet assay, each sample was mixed with low melting-point agarose at 37°C to a final concentration of 0.5%. The mixture (100 μL) was added to the slides precoated with 1.5% normal-melting-point agarose to retain the agarose cell suspension. The drop containing cells was covered with a glass cover slip and left at 4°C for 5 min. The slides were treated with a lysis solution (2.5 M NaCl, 100 mM EDTA, 100 mM TRIS, 1% Triton X-100, 10% DMSO, pH ~ 10.2) for 24 h at 4°C. After, the slides were placed horizontally on an electrophoresis tray and the resultant nucleoids were immersed in electrophoresis buffer (300 mM NaOH, 100 mM EDTA, pH > 13) for 20 min at 4°C to cleave the alkali-labile sites. Then the electrophoresis was started using an electric field of 23 V/cm for 20 min. At the end of the process, the slides were gently removed from the tray and washed with distilled water for 5 min for neutralization. The slides were dehydrated for 3 min in absolute ethanol and were then air dried. Finally, the slides were stained with ethidium bromide (20 μg/mL) and viewed using fluorescence microscopy ZEISS AxioCam HRc with green barrier filter 510–560 nm and 400x coupled to a video camera. The cell images were analyzed using Tritek Comet Score Freeware 1.6 software. Registered parameters included the percent of DNA in the tail (Tail DNA %), Tail Length (TL), Tail Moment (TM), and Olive Moment (OM) as marker of DNA damage. One hundred comets were scored randomly for each concentration employed. All steps described previously were carried out in a darkroom to prevent the interference of additional DNA damage.
Statistical analyses were performed using Graphpad Prism 6 software (GraphPad Software Inc., La Jolla, USA). We assessed differences in the survival groups after CLP using Kaplan-Meier analysis followed by a log-rank test. Other data were analyzed using Analysis of Variance (ANOVA) followed by Tukey multiple comparison test. Data are presented as mean ± SD values. In all cases the significance level adopted was 5% (p < 0.05).
In the present study, we showed for the first time the immunomodulatory and antioxidant protective effect of prophylactic A. brasiliensis aqueous extract treatment in the CLP-induced sepsis. Ab protected mice against sepsis by increasing bacterial clearance and survival, maintaining normal hematological parameters. The pretreatment with Ab reduced the systemic levels of inflammatory cytokines (TNF-α, IL-1β), increased the antioxidant response in several organs and tissues (GSH and TEAC) with concomitant inhibition of oxidative damage (lipid peroxidation in serum, peritoneal cavity, heart and liver) of septic mice.
Ab is a basidiomycete mushroom considered nutraceutical. Our group have reported that Ab has bioactive compounds such as phytosterols, aromatic amino acids, flavonoids and phenolic compounds (33). Phenolic compounds have a high antioxidant capacity according to their structure, depending on the number and position of the hydroxyl and act through enzymatic inhibition or in the trace elements sequestration, reducing reactive species formation (34). In addition, the aqueous extract of Ab is rich in polysaccharides such as β-glucans (11), which can activate leukocytes and increase phagocytosis and antimicrobial activity (35, 36).
In this study, Ab improved the survival of septic mice by an immunomodulatory mechanism. Our data are in agreement with previous reports showing that oral supplementation of Ab improved Crohn’s disease through the reduction of systemic pro-inflammatory cytokines such as IL-1β, IL-6 and G-CSF. In addition, patients with ulcerative colitis presented decreased levels of IL-2, IL-5 and MIP-1β after 21 days of consumption compared placebo group (37). Moreover, the antitumor effect in multiple myeloma and cervical cancer mediated by an immunomodulatory activity have been reported (38, 39). These antimicrobial, antioxidant and immunomodulation properties described in preclinical and clinical studies with Ab supplementation may be associated with bioactive compounds found in mushroom, such as phenolic compounds, organic acids, amino acids and β-glucans (11, 12).
In sepsis, the pretreatment with antibiotics have a role to prevent complications such as systemic infections, reducing the mortality of patients (40). Here, the pretreatment with aqueous extract of Ab modulated the systemic and local release of proinflammatory cytokines, inhibited the leukocyte infiltration into peritoneal cavity, increased phagocytosis and NO production in infectious focus, leading to complete inhibition of bacterial burden in blood and peritoneal cavity. Smiderle et al. showed that the expression of proinflammatory cytokines (TNF-α and IL-1β) in LPS-stimulated THP-1 macrophages were inhibited by in vitro incubation with Ab-isolated β-glucans in presence of LPS (35). In addition, it was showed that the β-glucans negatively downregulated TLR-2 and TLR-4 receptors, decreasing exacerbated systemic immune system activation (41). It is important to point out that until now, there are no studies with A. braziliensis aqueous extract or any isolated compound in sepsis model.
In relation to the primary site of infection, Ab treatment modulated the inflammatory response into peritoneal cavity of septic mice, inducing almost complete bacterial burden elimination 24 h post CLP and a significant augment in NO levels, without alterations in IL-1β and TNF-α levels in relation to CLP-saline treated mice. In agreement, it was demonstrated that (16)-β-D-glucans activates dectin-1 receptors in monocytes, neutrophils and dendritic cells leading to phosphorylation of Syk and activation of CARD9/Bcl10/MALT-1 4 with consequent augment in phagocytic capacity and increased generation of ROS and RNS (42). Furthermore, according to Vitak et al., Ab is rich in arginine, a precursor to nitric oxide production by NO synthases responsible for the conversion of L-arginine to NO and L-citrulline (43).
Studies have shown that NO has dual effect during sepsis. NO contributes to elimination of pathogens through DNA nitrosation and desamination and inhibiting the action of bacterial DNA repair enzymes at the site of infection (44). On the other hand, studies have shown that NO modulates the expression of adhesion molecules and reduces leukocyte recruitment which can lead to microvascular dysfunction (45). However, although pretreatment with Ab reduced migration of leukocytes we observed an increase in NO levels and decreased bacterial burden. This may be due to the immunomodulatory property of Ab which might be correlated with increased phagocytic capacity and mechanisms reported above (44).
In addition, in sepsis the uncontrolled inflammatory response can cause oxidative stress, that plays a critical role in the pathogenesis and dysfunctions in multiple organs (46). In this respect our data showed that macrophages from septic animals produce higher levels of ROS compared to cells from sham or Ab treated animals. Moreover, Ab was able to inhibit the production of ROS by macrophages stimulated in vitro with tBHP, and also tBHP-induced DNA damage in human PBMC. In this context, Angeli et al. reported that the pretreatment with β-glucans extracted from Ab presented protective effect in human hepatic cells against the genotoxic and mutagenic effects of carcinogenic compound (Benzo[a]Pyrene) (47).
In septic patients, MDA levels are elevated and may be correlated with clinical worsening (48, 49). In our study, the levels of lipid peroxidation were significantly decreased in serum, peritoneal cavity, heart and liver of septic animals treated with Ab. These results are in agreement with evidences showing that the association of oxidative stress with systemic abnormalities in microcirculatory blood flow lead to cardiovascular and hepatic changes, that contributes to the high mortality of patients (50). In fact, Yan et al. reported that in CLP model, liver tissue damage starts ~1 h after sepsis, while cardiac dysfunction starts at 6 h (50).
In relation to the antioxidant defense, decreased levels of GSH and the inhibition of total antioxidant capacity are associated with organ failure and high mortality in sepsis (51). In contrast to septic animals, Ab-treated animals showed increased TEAC and GSH levels in serum and peritoneal cavity, and also enhanced antioxidant capacity in heart in liver tissues, as well as increased MDA/TEAC ratios in serum, peritoneal cavity, heart and liver, suggesting that the protective effect of Ab in CLP model is at least in part due to its antioxidant property.
Recently, De Souza et al. showed that the treatment of adjuvant-induced arthritic rats with Ab aqueous extract, at dose of 400 mg/kg, cause significant decrease in lipid damage in liver, brain, and plasma of treated rats. Moreover, the extract maintained the antioxidant defense, preserving the levels of reduced glutathione and protein thiol (52). In this line, it was demonstrated that in diabetic rats, the administration of Ab restored superoxide dismutase, catalase, and gluthatione peroxidase activity (43). This ability may be, at least in part, due to the presence of glutamic acid and glycine in Ab, since these amino acids are precursors of GSH synthesis, where glutamic acid reacts with cysteine to produce γ-glutamylcysteine (GCS) and subsequently reacts with glycine to form GSH (11, 53).
In conclusion, it was showed for the first time that the pretreatment with Ab aqueous extract was able to increase the survival of septic animals by a mechanism involving immunomodulatory and antioxidant protective effects as summarized in Figure 6. Further studies are needed to better elucidate the immunomodulatory mechanisms and ensure the safety of their clinical use.
Data Availability Statement
The datasets generated for this study are available on request to the corresponding author.
This study was carried out in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals of the Brazilian National Council of Animal Experimentation (http://www.sbcal.org.br/) and the NIH Guidelines for the Care and Use of Laboratory Animals. The institutional Committee for Animal Ethics of Federal University of Pará/UFPA (CEUA, Protocol: 02/15) approved all the procedures used in this study. The in vitro tests, human venous blood was collected from healthy volunteers signing the Informed Consent Form (ICF). This study was approved by the Institutional Committee of Ethics in Research involving human beings from the health sciences sector of UFPA (CEP-ICS/UFPA), under n° 3544380 and CAAE 12776619.0.0000.0018.
KN-L and MM designed the study. KN-L, VM, AO, SF, and JO conducted most of the experiments and wrote the main manuscript. HS and VS donated Agaricus brasiliensis. CR and JR conducted oxidative stress assay. RS conducted most of the experiments. AP and PR performed quantification of cytokines corrected the manuscript. All authors read and approved the final manuscript.
This research was funded by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação Amazônia Paraense de Amparo à Pesquisa (FAPESPA), and Federal University of Pará (UFPA). MM, AP, and PR are grateful to CNPq for the PQ productivity scholarship.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Ab, Agaricus brasiliensis; ABTS, 2,2′-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid); ANOVA, Analysis of Variance; Bcl10, B-Cell Lymphoma/Leukemia 10; CARD9, Caspase Recruitment Domain-Containing Protein 9; CEF, Ceftriaxone; CFU, Colony-Forming Units; CLP, Cecal Ligation and Puncture; DCF, Dichloro-Fluorescein; DMSO, Dimethylsulfoxide; DTNB, 5,5′-Dithiobis (2-nitrobenzoic acid); EDTA, Ethylenediamine Tetraacetic Acid; ELISA, Enzime-Linked Immunosorbent Assay; FBS, Fetal Bovine Serum; GCS, Glutamylcysteine Synthase; G–CSF, Granulocyte Colony-Stimulating Factor; GSH, Glutathione; H2DCF-DA, Dichlorodihydrofluorescein Diacetate; HEPES, 4-(2-Hydroxyethyl)-1-Piperazineethanesulfonic Acid; ICF, Informed Consent Form; IL, Interleukin; LPS, Lipopolysaccharide; MALT1, Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1; MDA, Malondialdehyde; MIP-1β, Macrophage Inflammatory Protein 1β; NF-κB, Nuclear Factor Kappa B; NO, Nitric Oxide; NO2, Nitrite; OM, Olive Moment; PBMC, Peripheral Blood Mononuclear Cells; PBS, Phosphate-Buffered Saline; PPARα, Peroxisome Proliferator-Activated Receptor alpha; RNS, Reactive Nitrogen Species; ROS, Reactive Oxygen Species; RPMI, Roswell Park Memorial Institute; TAS, Total Antioxidant Status; TBA, Thiobarbituric Acid; TBARS, Thiobarbituric Acid-Reactive Substances; tBHP, tert-Butyl Hydroperoxide; TCA, Trichloroacetic Acid; TEAC, Trolox Equivalent Antioxidant Capacity; TL, Tail Length; TLR, Toll-Like Receptor; TM, Tail Moment; TNF-α, Tumor Necrosis Factor Alpha.